home / stock / eidx / eidx quote
Last: | $122.21 |
---|---|
Change Percent: | -4.85% |
Open: | $127.57 |
Close: | $122.21 |
High: | $128.49 |
Low: | $116.83 |
Volume: | 334,481 |
Last Trade Date Time: | 01/25/2021 04:55:48 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$122.21 | $127.57 | $122.21 | $128.49 | $116.83 | 334,481 | 01-25-2021 |
$128.44 | $120.92 | $128.44 | $128.63 | $119.74 | 54,398 | 01-22-2021 |
$122.53 | $124.92 | $122.53 | $126.35 | $121.97 | 43,187 | 01-21-2021 |
$125.07 | $128.77 | $125.07 | $131.0842 | $124.63 | 68,325 | 01-20-2021 |
$128.14 | $126.87 | $128.14 | $128.55 | $126.135 | 343,607 | 01-19-2021 |
$126.51 | $126.5 | $126.51 | $129.24 | $123.62 | 89,215 | 01-18-2021 |
$126.51 | $126.5 | $126.51 | $129.24 | $123.62 | 89,215 | 01-15-2021 |
$128.51 | $122.51 | $128.51 | $129.19 | $120.04 | 125,181 | 01-14-2021 |
$121.85 | $125.66 | $121.85 | $126.87 | $121.85 | 171,282 | 01-13-2021 |
$126.28 | $126.5 | $126.28 | $127.72 | $124.085 | 58,892 | 01-12-2021 |
$126.5 | $119.95 | $126.5 | $126.75 | $119.95 | 66,445 | 01-11-2021 |
$120.96 | $119.81 | $120.96 | $122.3981 | $116.49 | 95,334 | 01-08-2021 |
$119.27 | $118.94 | $119.27 | $121 | $118.585 | 162,132 | 01-07-2021 |
$118.34 | $119.7 | $118.34 | $121.28 | $117.27 | 91,323 | 01-06-2021 |
$119.97 | $116.52 | $119.97 | $121.73 | $116.24 | 51,297 | 01-05-2021 |
$117.32 | $132.54 | $117.32 | $132.54 | $116.62 | 150,892 | 01-04-2021 |
$131.58 | $129.33 | $131.58 | $131.89 | $126.73 | 59,320 | 01-01-2021 |
$131.58 | $129.33 | $131.58 | $131.89 | $126.73 | 59,319 | 12-31-2020 |
$129.34 | $124.98 | $129.34 | $130.66 | $124.98 | 57,565 | 12-30-2020 |
$124.61 | $128.12 | $124.61 | $128.12 | $122.54 | 61,210 | 12-29-2020 |
News, Short Squeeze, Breakout and More Instantly...
Eidos Therapeutics Inc. Company Name:
EIDX Stock Symbol:
NASDAQ Market:
Eidos Therapeutics Inc. Website:
PALO ALTO, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: BBIO) today announced that it has completed its acquisition of all of the outstanding shares of Eidos Therapeutics, Inc. (“Eidos”) (formerly Nasdaq: EIDX) common st...
PALO ALTO, Calif. and SAN FRANCISCO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: BBIO) and Eidos Therapeutics, Inc. (“Eidos”) (Nasdaq: EIDX) today announced that the stockholders of each of BridgeBio and Eidos voted to approve ...
PALO ALTO, Calif. and SAN FRANCISCO, Jan. 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: BBIO) and Eidos Therapeutics, Inc. (“Eidos”) (Nasdaq: EIDX) announced today that the acquisition of shares of common stock of Eidos not held by Br...